RGLBX | RWICX | RGLBX / RWICX | |
Total Expense Ratio | 1.52 | 1.06 | 143% |
Annual Report Gross Expense Ratio | 1.52 | 1.06 | 143% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 17.425 | 18.816 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.5B | 141B | 13% |
Annual Yield % from dividends | 0.21 | 1.18 | 18% |
Returns for 1 year | 15.55 | 12.97 | 120% |
Returns for 3 years | 58.48 | 57.57 | 102% |
Returns for 5 years | 58.75 | 51.00 | 115% |
Returns for 10 years | N/A | 78.93 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 28.00 | 0.16 | +0.59% |
First Trust Nasdaq Pharmaceuticals ETF | |||
XOCT | 36.74 | N/A | -0.01% |
FT Vest US Eq Enh & Mod Buf ETF-Oct | |||
XMMO | 133.69 | -0.07 | -0.05% |
Invesco S&P MidCap Momentum ETF | |||
HYG | 81.05 | -0.08 | -0.10% |
iShares iBoxx $ High Yield Corp Bd ETF | |||
IBND | 32.56 | -0.12 | -0.37% |
SPDR® Blmbg Intl Corp Bd ETF |